Experts from Kodak and Acsis will help brand owners navigate threats and challenges to protect end consumers from counterfeit or diverted medications at the fourth annual Anti-Counterfeiting Summit for Pharmaceuticals and Medical Devices, taking place from 22-24 May in Philadelphia.
The Anti-Counterfeiting Summit will feature Kodak and Acsis on the topic of Leveraging Serialisation/e-Pedigree Mandates to Achieve Brand Protection and Operational Efficiency on May 24 at 9:45a.m. The session will outline the immediate and long-term benefits of an enterprise serialisation solution and create a roadmap to help decision makers plan and implement a brand protection programme.
Impending legislation changes such as Californias e-Pedigree mandate and the European Unions Safe Medicines Directive are making companies re-examine their supply chains and serialisation, said John DiPalo, COO, Acsis. The time is right for brands to consider options that will improve their distribution and sales channels, as well as provide protection from diversion and counterfeiting. Kodak and Acsis are delivering exactly that type of solution.
Kodak has teamed up with industry software and hardware leaders to deliver fully customised brand protection solutions with best-in-class track and trace software, vision camera systems, handheld barcode readers, and packaging line integration, coupled with the KODAK TRACELESS Solutions family of covert markers, smartphone apps, Incident Monitoring System and Brand Protection Services portfolio.
Kodak and Acsis offer a powerful arsenal to help combat counterfeiting and diversion, which annually cost billions, burden the healthcare system, and put people seeking aid at tremendous risk, said Keith Cutri, Director, Business Development, Kodaks Brand Protection Services and a former FBI special agent with more than 25 years of private industry experience. With dual serialisation marking and coding systems, Kodak is empowering brands to become more effective at monitoring, detecting and enforcing measures against diversion and counterfeiting.